Intravenous Lidocaine in Carcinologic ENT Surgery: A Trial for Evaluation of Opioid Saving Strategy and Chronic Post-surgical Pain (ELICO)

NCT02894710 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

OTHER

Sponsor class

Conditions

Carcinologic Ear, Nose, and Throat (ENT) Surgery

Interventions

DRUG: Lidocaine 20mg/ml
DRUG: Glucose 5% (placebo)

Sponsor

Hospices Civils de Lyon